Prevalence and prognostic implications of active cytomegalovirus infection in patients with acute heart failure

Clinical Science

Volumn 119, Issue 10, 2010, Pages 443-452

  Núñez, Julio ^a   Chilet, Marifina ^a   Sanchis, Juan ^a   Bodí, Vicent ^a   Núñez, Eduardo ^a   Miñana, Gema ^a   Tormo, Nuria ^b   Clari, Maria A ^a   Pellicer, Mauricio ^a   Chorro, Francisco J ^a   Llàcer, Angel ^a   Navarro, David ^a,b  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Acute heart failure; Cytomegalovirus infection; Inflammation; Mortality; Risk stratrification

Indexed keywords

CHEMOKINE; CYTOKINE; VIRUS DNA;

ACUTE HEART FAILURE; ADULT; AGED; ARTICLE; CAUSE OF DEATH; CYTOMEGALOVIRUS INFECTION; DISEASE COURSE; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; VIRUS REACTIVATION;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; CYTOKINES; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DNA, VIRAL; EPIDEMIOLOGIC METHODS; FEMALE; HEART FAILURE; HUMANS; INFLAMMATION MEDIATORS; LENGTH OF STAY; MALE; MIDDLE AGED; PATIENT READMISSION; PROGNOSIS; VIRUS ACTIVATION;

EID: 77956413875     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20100162     Document Type: Article

References (27)

1. Stewart, S., MacIntyre, K., Hole, D. J., Capewell, S. and McMurray, J. J. (2001) More 'malignant' than cancer? Five-year survival following a first admission for heart failure. Eur. J. Heart Failure 3, 315-322
2. von Haehling, S., Schefold, J. C., Lainscak, M., Doehner, W. and Anker, S. D. (2009) Inflammatory biomarkers in heart failure revisited: much more than innocent bystanders. Heart Failure Clin. 5, 549-560
3. Yndestad, A., Damås, J. K., Oie, E., Ueland, T., Gullestad, L. and Aukrust, P. (2006) Systemic inflammation in heart failure: the whys and wherefores. Heart Failure Rev. 11, 83-92
4. Torre-Amione, G. (2005) Immune activation in chronic heart failure. Am. J. Cardiol. 95, 3C-8C
5. Cook, C. H., Trgovcich, J., Zimmerman, P. D., Zhang, Y. and Sedmak, D. D. (2006) Lipopolysaccharide, tumor necrosis factor α, or interleukin-1β triggers reactivation of latent cytomegalovirus in immunocompetent mice. J. Virol. 80, 9151-9158
6. Crough, T. and Khanna, R. (2009) Immunobiology of human cytomegalovirus infection: from bench to bedside. Clin. Microbiol. Rev. 22, 76-98
7. Bruggeman, C. A. (2000) Does cytomegalovirus play a role in atherosclerosis? Herpes 7, 51-54
8. Zhu, J., Shearer, G. M., Norman, J. E., Pinto, L. A., Marincola, F. M., Prasad, A., Waclawiw, M. A., Csako, G., Quyyumi, A. A. and Epstein, S. E. (2000) Host response to cytomegalovirus infection as a determinant of susceptibility to coronary artery disease: sex-based differences in inflammation and type of immune response. Circulation 102, 2491-2496
9. Prösch, S., Staak, K., Stein, J., Liebenthal, C., Stamminger, T., Volk, H. D. and Krüger, D. H. (1995) Stimulation of the human cytomegalovirus IE enhancer/promoter in HL-60 cells by TNF-α is mediated via induction of NF-κB. Virology 208, 197-206
10. Döcke, W. D., Prösch, S., Fietze, E., Kimel, V., Zuckermann, H., Klug, C., Syrbe, U., Krüger, D. H., von Baehr, R. and Volk, H. D. (1994) Cytomegalovirus reactivation and tumor necrosis factor. Lancet 343, 268-269
11. Dickstein, K., Cohen-Solal, A., Filippatos, G., McMurray, J. J., Ponikowski, P., Poole-Wilson, P. A., Strömberg, A., van Veldhuisen, D. J., Atar, D., Hoes, A. W. et al. (2008) ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur. J. Heart Failure 10, 933-989
12. Gimeno, C., Solano, C., Latorre, J. C., Hernández-Boluda, J. C., Clari, M. A., Remigia, M. J., Furió, S., Calabuig, M., Tormo, N. and Navarro, D. (2008) Quantification of DNA in plasma by an automated real-time PCR assay (CMV PCR Kit, Abbott) for surveillance of active cytomegalovirus infection and guidance of pre-emptive therapy for allogeneic hematopoietic stem cell transplant recipients. J. Clin. Microbiol. 46, 3311-3318
13. Royston, P. and Sauerbrei, W. (2008) Multivariable Model-building: a Pragmatic Approach to Regression Analysis Based on Fractional Polynomials for Modelling Continuous Variables, Wiley-Blackwell, Chichester
14. May, S. and Hosmer, D. W. (2004) Hosmer and Lemeshow type goodness-of-fit statistics for the Cox proportional hazards model. Advances in Survival Analysis: Handbook of Statistics, vol. 23 (Balakrishnana, N. and Rao, C. R., eds.), pp. 383-394, Elsevier, Amsterdam
15. Fildes, J. E., Shaw, S. M., Yonan, N. and Williams, S. G. (2009) The immune system and chronic heart failure: is the heart in control? J. Am. Coll. Cardiol. 53, 1013-1020
16. Miettinen, K. H., Lassus, J., Harjola, V. P., Siirilä-Waris, K., Melin, J., Punnonen, K. R., Nieminen, M. S., Laakso, M. and Peuhkurinen, K. J. (2008) Prognostic role of pro- and anti-inflammatory cytokines and their polymorphisms in acute decompensated heart failure. Eur. J. Heart Failure 10, 396-403
17. Chen, D., Assad-Kottner, C., Orrego, C. and Torre-Amione, G. (2008) Cytokines and acute heart failure. Crit. Care Med. 36, S9-S16
18. Kalil, A. C. and Florescu, D. F. (2009) Prevalence and mortality associated with cytomegalovirus infection in nonimmunosuppresed patients in the intensive care unit. Crit. Care Med. 37, 2350-2358
19. Limaye, A. P., Kirby, K. A., Rubenfeld, G. D., Leisenring, W. M., Bulger, E. M., Neff, M. J., Gibran, N. S., Huang, M. L., Santo Hayes, T. K., Corey, L. and Boeckh, M. (2008) Cytomegalovirus reactivation in critically ill immunocompetent patients. JAMA, J. Am. Med. Assoc. 300, 413-422
20. Osawa, R. and Singh, N. (2009) Cytomegalovirus infection in critically ill patients: a systematic review. Crit. Care 13, R68
21. Söderberg-Nauclér, C. (2006) Does cytomegalovirus play a causative role in the development of various inflammatory diseases and cancer? J. Intern. Med. 259, 219-246
22. Varani, S., Frascaroli, G., Landini, M. P. and Söderberg- Nauclér, C. (2009) Human cytomegalovirus targets different subsets of antigen-presenting cells with pathological consequences for host immunity: implications for immunosuppression, chronic inflammation and autoimmunity. Rev. Med. Virol. 19, 131-145
23. von Muller, L., Klemm, A., Durmus, N., Weiss, M., Suger-Wiedeck, H., Schneider, M., Hampl, W. and Mertens, T. (2007) Cellular immunity and active cytomegalovirus infection in patients with septic shock. J. Infect. Dis. 196, 288-295
24. Vornhagen, R., Plachter, B., Hinderer, W., The, T. H., Van Zanten, J., Matter, L., Schmidt, C. A., Sonneborn, H. H. and Jahn, G. (1994) Early serodiagnosis of acute human cytomegalovirus infection by enzyme-linked immunosorbent assay using recombinant antigens. J. Clin. Microbiol. 32, 981-986
25. Lin, L., Kim, S. C., Wang, Y., Gupta, S., Davis, B., Simon, S. I., Torre-Amione, G. and Knowlton, A. A. (2007) HSP60 in heart failure: abnormal distribution and role in cardiac myocyte apoptosis. Am. J. Physiol. Heart Circ. Physiol. 293, H2238-H2247
26. Kim, S. C., Stice, J. P., Chen, L., Jung, J. S., Gupta, S., Wang, Y., Baumgarten, G., Trial, J. and Knowlton, A. A. (2009) Extracellular heat shock protein 60, cardiac myocytes, and apoptosis. Circ. Res. 105, 1186-1195
27. Bason, C., Corrocher, R., Lunardi, C., Puccetti, P., Olivieri, O., Girelli, D., Navone, R., Beri, R., Millo, E., Margonato, A. et al. (2003) Interaction of antibodies against cytomegalovirus with heat-shock protein 60 in pathogenesis of atherosclerosis. Lancet 362, 1971-1977 (Pubitemid 37548421)